Vaccines, Blood & Biologics
-
Filing Memo Reminder Email, February 8, 2012 pm - Octaplas
From: Mullersman, Jerald
Sent: Wednesday, February 08, 2012 3:25 PM
To: Rana, Pratibha; Lee, Timothy; Mahmood, Iftekhar; Stockbridge, Lisa L; Holobaugh, Patricia; Austin-Hansberry, Lori; Kim, Jessica; Rees, Renee; Boxenbaum, Harold; Green, Damon; Kirschbaum, Nancy; Drabick, Christine; Malla, Amy; He, Jie; Brony, Michael; Frost, Mitchell M; Kirschbaum, Nancy; Kim, Jessica; Melhem, Randa; Peng, Ze; Ovanesov, Mikhail V.; Wyatt, Michael (Keith)
Cc: Nguyen, Michael D.
Subject: RE: Reminder Filing memo due: Filing Meeting/STN 125416/0/OctaplastLG/Pratibha
Pratibha,
As I noted in the meeting yesterday, the OctaplasLG BLA submission, while fileable, does not include a pharmacovigilance plan. Here is some letter-ready text (in quotes below) that might be included in the filing memo that is being sent to Octapharma:
"Pursuant to the ICH E2E Pharmacovigilance Planning Guideline April 2005, it is recommended that Octapharma submit a pharmacovigilance plan containing the elements delineated in the ICH E2E guidelines (which can be accessed at http://www.fda.gov/RegulatoryInformation/Guidances/ucm129411.htm). Rapid submission of this plan in a complete form will facilitate timely review of the application."
Thanks,
Jerry Mullersman
Jerald Mullersman, MD, PhD, MPH
Medical Officer
FDA/CBER/OBE/DE/PVB HFM-224
1401 Rockville Pike, Suite 400 S
Rockville, MD 20852
Office: (301) 827-2952
_____________________________________________
From: Rana, Pratibha
Sent: Wednesday, February 08, 2012 11:14 AM
To: Lee, Timothy; Mahmood, Iftekhar; Stockbridge, Lisa L; Holobaugh, Patricia; Austin-Hansberry, Lori; Kim, Jessica; Rees, Renee; Boxenbaum, Harold; Green, Damon; Kirschbaum, Nancy; Drabick, Christine; Malla, Amy; He, Jie; Brony, Michael; Frost, Mitchell M; Kirschbaum, Nancy; Mullersman, Jerald; Kim, Jessica; Melhem, Randa; Peng, Ze; Ovanesov, Mikhail V.; Wyatt, Michael (Keith)
Subject: RE: Reminder Filing memo due: Filing Meeting/STN 125416/0/OctaplastLG/Pratibha
Please don’t forget to Cc your supervisor also if you are writing an email.
Thanks
Pratibha
_____________________________________________
From: Rana, Pratibha
Sent: Wednesday, February 08, 2012 11:06 AM
To: Jain, Nisha; Lee, Timothy; Mahmood, Iftekhar; Stockbridge, Lisa L; Holobaugh, Patricia; Austin-Hansberry, Lori; Kim, Jessica; Rees, Renee; Boxenbaum, Harold; Green, Damon; Kirschbaum, Nancy; Drabick, Christine; Malla, Amy; He, Jie; Brony, Michael; Frost, Mitchell M; Kirschbaum, Nancy; Mullersman, Jerald; Kim, Jessica; Melhem, Randa; Peng, Ze; Ovanesov, Mikhail V.; Wyatt, Michael (Keith)
Subject: Reminder Filing memo due: Filing Meeting/STN 125416/0/OctaplastLG/Pratibha
Hello All,
This is a reminder to upload your signed off Filing memo by Friday February 10, 2012.
If you are writing a filing memo as email please CC me and the chairperson, Nancy Kirshbaum.
Thanks
Pratibha
_____________________________________________
From: Rana, Pratibha
Sent: Thursday, January 05, 2012 1:38 PM
To: Rana, Pratibha; Rana, Pratibha; Jain, Nisha; Lee, Timothy; Mahmood, Iftekhar; Stockbridge, Lisa L; Holobaugh, Patricia; Austin-Hansberry, Lori; Kim, Jessica; Rees, Renee; Boxenbaum, Harold; Green, Damon; Kirschbaum, Nancy; Drabick, Christine; Malla, Amy; He, Jie; Brony, Michael; Frost, Mitchell M; Kirschbaum, Nancy; Mullersman, Jerald; Kim, Jessica; Melhem, Randa; Peng, Ze; Ovanesov, Mikhail V.; Wyatt, Michael (Keith)
Subject: Filing Meeting/STN 125416/0/OctaplastLG/Pratibha
When: Tuesday, February 07, 2012 1:00 PM-2:00 PM (GMT-05:00) Eastern Time (US & Canada).
Where: CBER Conf. WOC-400S
( if you are unable to attend in person and by phone) please send an email answering the following topics to SL, Nancy Kirshbaum and me).
STN 125416/0
Product: Pooled Plasma, Solvent Detergent Treated (Human)
Sponsor: Octapharma
Filing Meeting:
To determine if this BLA is fileable/RTF/Deficiencies
Decision on priority review or not
Call in info for those who cannot attend in person:
------(b)(4)---------
Participant code: ---(b)(4)----
Thanks
Pratibha
-
-







